Items where authors include "Hassani, A."

Article

Hayrapetyan, A., Tumasyan, A. orcid.org/0009-0000-0684-6742, Adam, W. orcid.org/0000-0001-9099-4341 et al. (5283 more authors) (2024) Combination of measurements of the top quark mass from data collected by the ATLAS and CMS experiments at s = 7 and 8 TeV. Physical Review Letters, 132. 261902. ISSN 0031-9007

Hayrapetyan, A., Tumasyan, A. orcid.org/0009-0000-0684-6742, Adam, W. orcid.org/0000-0001-9099-4341 et al. (5283 more authors) (2024) Combination of measurements of the top quark mass from data collected by the ATLAS and CMS experiments at s =7 and 8 TeV. Physical Review Letters, 132. 261902. ISSN 0031-9007

Aad, G. orcid.org/0000-0002-6665-4934, Abbott, B. orcid.org/0000-0002-5888-2734, Abeling, K. orcid.org/0000-0002-1002-1652 et al. (5287 more authors) (2024) Evidence for the Higgs boson decay to a Z boson and a photon at the LHC. Physical Review Letters, 132 (2). 021803. ISSN 0031-9007

Aad, G., Abbott, B., Abbott, D.C. et al. (5241 more authors) (2023) Combination of inclusive top-quark pair production cross-section measurements using ATLAS and CMS data at s√ = 7 and 8 TeV. Journal of High Energy Physics, 2023 (7). 213. ISSN 1126-6708

Tumasyan, A. orcid.org/0009-0000-0684-6742, Adam, W. orcid.org/0000-0001-9099-4341, Andrejkovic, J.W. et al. (2348 more authors) (2023) Measurement of the mass dependence of the transverse momentum of lepton pairs in Drell–Yan production in proton–proton collisions at √s = 13 TeV. The European Physical Journal C, 83 (7). 628. ISSN 1434-6044

Proceedings Paper

Greystoke, A., Oughton, J.B., Brown, S.R. et al. (16 more authors) (2024) Olaparib, AZD1390, ceralasertib, saruparib and consolidation durvalumab (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer (NSCLC). In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. ASCO Publications .

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier BV , S296-S297.

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier , S296-S297.